Area of research
Cancer Research · Immunology
Research interest
Research interests include MicroRNA in disease regulation, Immune Response and Inflammation, Cancer-related molecular mechanisms research, and Platelet Disorders and Treatments.
MicroRNA-9-3p inhibits endothelial pyroptosis in atherosclerosis by targeting the PTEN/AKT axis
Pyroptosis-Related Gene Signature and Expression Patterns in the Deterioration of Atherosclerosis
Evodiamine exerts inhibitory roles in non‑small cell lung cancer cell A549 and its sub‑population of stem‑like cells
Expression and Regulatory Network Analysis of BICC1 for Aged Sca-1-Positive Bone Narrow Mesenchymal Stem Cells
Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data
Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets
Anti-β2GPI/β2GPI complexes induce platelet activation and promote thrombosis via p38MAPK: a pathway to targeted therapies
The correlation of vitamin D with risk and severity of acute ischemic stroke
Anti-β2GPI/β2GPI induces neutrophil extracellular traps formation to promote thrombogenesis via the TLR4/MyD88/MAPKs axis activation
Platelets activated by the anti-β2GPI/β2GPI complex release microRNAs to inhibit migration and tube formation of human umbilical vein endothelial cells
Effect and mechanism of the aβ2‑GP I/rhβ2‑GP I complex on JEG‑3 cell proliferation, migration and invasion
Protective effects of tenuigenin on lipopolysaccharide and d -galactosamine-induced acute liver injury
Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2′ and glycoprotein I bα
Progress in the study on the role of anti-beta 2 glycoprotein I antibody in platelet activation and thrombosis
Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid–blood barrier
Data normalization for DNA methylation profiles of cancer genomes